Evaluating Effective Methods for Referral for Smoking Cessation Counseling and High Blood Pressure Follow-up

NCT ID: NCT03020836

Last Updated: 2017-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

473 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-30

Study Completion Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigators conducted a clinic-based study to determine the magnitude of uncontrolled hypertension and current smoking in eye doctor's offices and sought to determine if referral to care results in actions taken by the patient.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Smoking and hypertension are two modifiable risk factors that are linked to highly prevalent chronic diseases such as diabetes and cardiovascular disease. The ophthalmology waiting room has the potential to be an effective point of intervention to provide referral to primary care in addition to health education on preventive health topics.

The investigators therefore, conducted a clinic-based study to determine the magnitude of uncontrolled hypertension and current smoking in eye doctor's offices and to determine if referral to care results in actions taken by the patient.

The investigators determined the proportion of patients who have elevated blood pressure. Patients were referred appropriately and the proportion of participants who followed the recommendation to meet with their primary care doctor for elevated blood pressure at 4-6 weeks and 8-10 weeks was determined. In addition, those who consented to be in the study and admitted to smoking cigarettes were offered smoking cessation assistance through a quit line. Investigators also followed up on cigarette smoking at 4-6 weeks and 8-10 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Smoking Cessation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hypertension patient referral

Referral to primary care physician for hypertension control: Patients with uncontrolled hypertension were referred to a primary care physician for treatment.

Group Type OTHER

Referral to primary care physician for hypertension control

Intervention Type BEHAVIORAL

Referral to primary care physician for hypertension control

Smoking cessation patient referral

Referral to smoking quit line: Patients that were current smokers were referred to the Maryland smoking cessation quit line if they were willing.

Group Type OTHER

Referral to smoking quit line

Intervention Type BEHAVIORAL

Referral to Maryland Tobacco/Smoking quit line for help with smoking cessation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Referral to primary care physician for hypertension control

Referral to primary care physician for hypertension control

Intervention Type BEHAVIORAL

Referral to smoking quit line

Referral to Maryland Tobacco/Smoking quit line for help with smoking cessation

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients \>18 years of age presenting to the glaucoma service and general eye service at Wilmer Eye Institute.

Exclusion Criteria

* Non-English speakers
* Unable to provide written informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Johns Hopkins University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

David S. Friedman

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NA_00089710

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Smoking Cessation in Alcoholics
NCT00963482 COMPLETED NA
Overcoming Nicotine Dependence to Enable Quitting
NCT05513872 RECRUITING PHASE1/PHASE2
Smoking Cessation in Hospitalized Smokers
NCT01289275 COMPLETED PHASE4
Improving Quitline Support Study
NCT03538938 COMPLETED PHASE4
Hospitalized Smokers
NCT01305928 COMPLETED NA